The Alzheimer’s Association has awarded BUSM Postdoctoral Fellow Jonathan Cherry, PhD, nearly $170,000 for his research, “Unique Neuroimmune Signature in Alzheimer’s Disease Compared to CTE.”
Cherry aims to clarify the role that inflammation plays in Alzheimer’s disease (AD) and chronic traumatic encephalopathy (CTE). He and his colleagues will determine where inflammation begins and how it spreads throughout the brain, specifically exploring how inflammation affects the spread of tau and beta-amyloid, two dementia-related proteins in AD and CTE brains. Their findings ultimately could help provide treatments for a number of neurodegenerative diseases that involve neuroinflammation.
The Alzheimer’s Association is the largest nonprofit funder of Alzheimer’s research in the world, having awarded more than $375 million to more than 2,400 scientific investigations. Their mission is to eliminate Alzheimer’s disease through the advancement of research, provide and enhance care and support for all affected, and reduce the risk of dementia through the promotion of brain health.